Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC37908 | BPC 157 |
BPC 157 is a 15-amino acid fragment of a gastric peptide, BPC, with hepatoprotective effects.
More description
|
![]() |
DC35062 | Biotin-PEG3-(CH2)3-NH2 TFA |
Biotin-PEG3-(CH2)3-NH2 TFA salt is PEG derivative containing a biotin group and a terminal primary amine group. The amine group can be coupled to carboxyl groups or 5'phosphate groups to form stable amide bonds. The hydrophilic PEG spacer increases solubility in aqueous media and increases membrane impermeability of the molecules conjugated to the biotin compound. It also helps to minimize steric hindrance involved with the binding to avidin molecules. Therefore, Biotin-PEG-amines may be useful in the development of antibody drug conjugates.
More description
|
![]() |
DC35716 | Azido-PEG1-t-butyl ester |
Azido-PEG1-t-butyl ester is a PEG derivative containing an azide group and a t-butyl ester. The hydrophilic PEG spacer increases solubility in aqueous media. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The t-butyl protected carboxyl group can be deprotected under acidic conditions.
More description
|
![]() |
DC34787 | Propargyl-PEG3-t-butyl ester |
Propargyl-PEG3-t-butyl ester is a PEG derivative containing a propargyl group and a t-butyl protected carboxyl group. The propargyl group can be reacted with azide-bearing compounds or biomolecules via copper catalyzed azide-alkyne Click Chemistry to yield a stable triazole linkage. The t-butyl protected carboxyl group can be deprotected under acidic conditions. The hydrophilic PEG spacer increases solubility in aqueous media.
More description
|
![]() |
DC34018 | (S)-Crizotinib |
(S)-Crizotinib is an MTH1 inhibitor. By inhibiting MTH1, (S)-Crizotinib disrupts nucleotide pool homeostasis, induces an increase in DNA single-strand breaks, activates DNA repair in human colon carcinoma cells, and effectively suppresses tumor growth in animal models.
More description
|
![]() |
DC37678 | CHM-081 |
JWH 081 is a cannabimimetic aminoalkylindole that shows a high-affinity for the central cannabinoid (CB1) receptor with a Ki value of 1.2 nM and ten-fold reduced affinity for the peripheral cannabinoid (CB2) receptor (Ki = 12.4 nM). JWH 081-N-(cyclohexylmethyl) analog is a synthetic CB where a cyclohexylmethyl group replaces the alkyl group of the parent compound. The physiological and toxicological properties of this compound are unknown.
More description
|
![]() |
DC34471 | GA3-AM |
GA3-AM is a cell permeable chemical dimerizer.
More description
|
![]() |
DC35874 | m-PEG8-succinimidyl carbonate |
m-PEG8-succinimidyl carbonate is a PEG Linker.
More description
|
![]() |
DC37899 | Spinorphin |
Spinorphin is a heptapeptide which is a potent inhibitor of enkephalin-degrading enzymes from the spinal cord or brain; does not show inhibitory activity toward enkephalin-degrading enzymes from kidney or blood; member of the opioid hemorphin family.
More description
|
![]() |
DC38089 | MDK71803 |
MDK71803 is an important intermediate or precursor for the synthesis of Cefiderocol. MDK71803 has CAS#137171-80-3. We assigned a code name as MDK71803 (last 5 digital of its CAS# was used). Cefiderocol, also known as S-649266, is a potent siderophore cephalosporin antibiotic with a catechol moiety on the 3-position side chain. S-649266 shows potent in vitro activity against the non-fermenting Gram-negative bacteria Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia, including MDR strains such as carbapenem-resistant A. baumannii and metallo-β-lactamase-producing P. aeruginosa.
More description
|
![]() |
DC34981 | Aminooxy-PEG7-methane |
Aminooxy-PEG7-methane is a PEG derivative containing an aminooxy group and a methane group. The aminooxy group can be used in bioconjugation. It reacts with an aldehyde to form an oxime bond. If a reductant is used, it will form a hydroxylamine linkage. PEG Linkers may be useful in the development of antibody drug conjugates or drug delivery methods.
More description
|
![]() |
DC34212 | U83836E |
U83836E is a potent lipid peroxidation (LP) inhibitor. It has been shown to suppress oxidative stress and activate PKC, improving neurodegeneration in diabetic retinopathy (DR).
More description
|
![]() |
DC33760 | 2-Acetyl-5-methylthiophene |
2-Acetyl-5-methylthiophene is a constituent of coffee aroma.
More description
|
![]() |
DC35596 | Methylamino-PEG1-acid HCl |
Methylamino-PEG1-acid HCl salt is a PEG derivative containing a carboxylic acid with a methylamine group. The hydrophilic PEG spacer increases solubility in aqueous media. The methylamine group is reactive with carboxylic acids, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.
More description
|
![]() |
DC36999 | Hexylresorcinol |
Hexylresorcinol is a substituted dihydroxybenzene used topically as an antiseptic for the treatment of minor skin infections. It also increases new bone formation by supression of Kappa B signaling pathway.
More description
|
![]() |
DC34448 | UK-78282 Hydrochloride |
UK-78282 HCl is a blocker of the KV1.3 and KV1.4 voltage-gated potassium channels.
More description
|
![]() |
DC36518 | Butyl benzoate |
Butyl benzoate as involatile solvent, for sampling of isocyanates with silica gel solid phase extraction. Butyl benzoate has been used as preservative in commercial cosmetic lotions. 3-(tert-Butyl)-4-hydroxyphenyl 2,4-dichlorobenzoate (1) was discovered as a moderate FXR antagonist. To improve the potency and the stability of the hit 1, forty derivatives were synthesized and SAR was systematically explored. The results turn out that replacing the 2,4-dichlorophenyl with 2,6-dichloro-4-amidophenyl shows great improvement in potency, replacing the benzoate with benzamide shows improvement in stability and slight declining of potency and 3-(tert-butyl)-4-hydroxyphenyl unit is essential in obtaining the FXR antagonistic activity.
More description
|
![]() |
DC37677 | JWH-424 |
JWH 018 is a synthetic cannabinoid (CB) that potently activates the central CB1 and peripheral CB2 receptors (Ki = 9.0 and 2.94 nM, respectively). This cannabimimetic compound has frequently been found in herbal blends. JWH 424 is an 8-bromonaphthyl derivative of JWH 018 which shows a reduced selectivity for CB1 over CB2 (Ki = 20.9 and 5.4 nM, respectively).
More description
|
![]() |
DC35304 | DNP-PEG3-DNP |
DNP-PEG3-DNP is a PEG Linker
More description
|
![]() |
DC35148 | t-Boc-N-amido-PEG2-acid |
t-Boc-N-amido-PEG2-acid is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. The Boc group can be deprotected under mild acidic conditions to form the free amine.
More description
|
![]() |
DC35244 | Chloroacetamido-PEG4-t-Butyl Ester |
Chloroacetamido-PEG4-t-Butyl Ester is a PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates.
More description
|
![]() |
DC36617 | Decabromobiphenyl |
Decabromobiphenyl is a flame retardant and a standard for environmental testing and research.
More description
|
![]() |
DC36299 | LP-922056 |
LP-922056 is a Notum pectinacetylesterase inhibitor which activates wnt signalling. LP-922056 increases cortical bone thickness in a mouse model of bone growth.
More description
|
![]() |
DC36589 | 21-deacetyldeflazacort |
21-Desacetyl Deflazacort is a metabolite of Deflazacort (sc-204709), which is a systemic corticosteroid and a derivative of prednisolone. It is used for lupus and rheumatoid arthritis.
More description
|
![]() |
DC35214 | Bromo-PEG6-alcohol |
Bromo-PEG6-alcohol is a PEG derivative containing a bromide group and a terminal hydroxyl group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The hydroxyl group enables further derivatization or replacement with other reactive functional groups.
More description
|
![]() |
DC34450 | Fendiline Hydrochloride |
Fendiline HCl is a potent acid sphingomyelinase (ASM) inhibitor, reducing the phosphatidylserine (PtdSer) and cholesterol content of the inner plasma membrane and inhibiting calcium function in muscle cells in excitation-contraction coupling.
More description
|
![]() |
DC36097 | Azilect |
Rasagiline is a selective and irreversible propargylamine inhibitor of monoamine oxidase type-B (MAO-B) that is not metabolized to amphetamine derivatives. Rasagiline exhibits neuroprotective and antiapoptotic activity against ischemia and several neurotoxins, including SIN-1, MPTP, 6-hydroxydopamine, and N-methyl-(R)-salsolinol.
More description
|
![]() |
DC34257 | GSK837149A |
GSK837149A is the first selective inhibitor of human fatty acid synthase (FAS).
More description
|
![]() |
DC34223 | Seretide |
Seretide is a combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of asthma and chronic obstructive pulmonary disease (COPD).
More description
|
![]() |
DC37922 | Hydrocortisone butyrate |
Hydrocortisone butyrate is a topical corticosteroid use to treat a variety of dermatological conditions. It acts as an antiinflammatory, antiproliferative and immunosuppresive agent.
More description
|
![]() |